Table 2: Immunotherapeutic drugs.

Anti–CTLA-4

Anti-PD-1 Antibody

TVEC

Ipilimumab

Nivolumab, Lambrolizumab, MPDL3280A

 

 

CTLA-4: cytotoxic T-lymphocyte antigen 4;  PD-1: Programmed Cell Death Protein 1